These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6199652)
61. Analysis of the protein-protein interactions in the parvovirus H-1 capsid. Paradiso PR J Virol; 1983 Apr; 46(1):94-102. PubMed ID: 6827655 [TBL] [Abstract][Full Text] [Related]
62. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812 [TBL] [Abstract][Full Text] [Related]
63. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1. Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609 [TBL] [Abstract][Full Text] [Related]
65. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity. Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499 [TBL] [Abstract][Full Text] [Related]
66. Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions. Grieger JC; Johnson JS; Gurda-Whitaker B; Agbandje-McKenna M; Samulski RJ J Virol; 2007 Aug; 81(15):7833-43. PubMed ID: 17507473 [TBL] [Abstract][Full Text] [Related]
67. Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors. Manaresi E; Gallinella G; Morselli Labate AM; Zucchelli P; Zaccarelli D; Ambretti S; Delbarba S; Zerbini M; Musiani M Epidemiol Infect; 2004 Oct; 132(5):857-62. PubMed ID: 15473148 [TBL] [Abstract][Full Text] [Related]
68. The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI. Meloen RH; Briaire J; Woortmeyer RJ; van Zaane D J Gen Virol; 1983 May; 64(Pt 5):1193-8. PubMed ID: 6188800 [TBL] [Abstract][Full Text] [Related]
70. A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2. Francis MJ; Hastings GZ; Sangar DV; Clark RP; Syred A; Clarke BE; Rowlands DJ; Brown F J Gen Virol; 1987 Oct; 68 ( Pt 10)():2687-91. PubMed ID: 2822846 [TBL] [Abstract][Full Text] [Related]
71. Location of an immunizing determinant within polypeptide VP1 of type O aphthovirus. Haresnape JM; King AM; McCahon D J Gen Virol; 1983 Nov; 64 (Pt 11)():2357-65. PubMed ID: 6196439 [TBL] [Abstract][Full Text] [Related]
72. Identification of three PPV1 VP2 protein-specific B cell linear epitopes using monoclonal antibodies against baculovirus-expressed recombinant VP2 protein. Sun J; Huang L; Wei Y; Wang Y; Chen D; Du W; Wu H; Feng L; Liu C Appl Microbiol Biotechnol; 2015 Nov; 99(21):9025-36. PubMed ID: 26153140 [TBL] [Abstract][Full Text] [Related]
73. The production of human parvovirus capsid proteins in Escherichia coli and their potential as diagnostic antigens. Rayment FB; Crosdale E; Morris DJ; Pattison JR; Talbot P; Clare JJ J Gen Virol; 1990 Nov; 71 ( Pt 11)():2665-72. PubMed ID: 1701479 [TBL] [Abstract][Full Text] [Related]
74. Cross-reactive and type-specific complement-fixing structures of Oriboca virions. Karabatsos N; Shope RE J Med Virol; 1979; 3(3):167-76. PubMed ID: 90121 [TBL] [Abstract][Full Text] [Related]
75. Temperature-sensitive mutants of foot-and-mouth disease virus with altered structural polypeptides. I. Identification by electrofocusing. King AM; Newman JW J Virol; 1980 Apr; 34(1):59-66. PubMed ID: 6246262 [TBL] [Abstract][Full Text] [Related]
76. Immunological reactivity of antisera to sodium dodecyl sulfate-derived polypeptides of polyoma virions. McMillen J; Consigli RA J Virol; 1977 Mar; 21(3):1113-20. PubMed ID: 191638 [TBL] [Abstract][Full Text] [Related]
77. Preparation and characterization of antisera to electrophoretically purified SA11 virus polypeptides. Bastardo JW; McKimm-Breschkin JL; Sonza S; Mercer LD; Holmes IH Infect Immun; 1981 Dec; 34(3):641-7. PubMed ID: 6174448 [TBL] [Abstract][Full Text] [Related]
78. Protein analysis of newly isolated variants of echovirus type 18 by electrophoresis and western blotting. Hayase Y; Toya K; Tanaka T; Tobita K J Med Virol; 1990 Nov; 32(3):143-7. PubMed ID: 2280258 [TBL] [Abstract][Full Text] [Related]
79. Identification of precursors of structural proteins VP1 and VP2 of hepatitis A virus. Kusov YYu ; Kazachkov YA; Dzagurov GK; Khozinskaya GA; Balayan MS; Gauss-Müller V J Med Virol; 1992 Jul; 37(3):220-7. PubMed ID: 1331311 [TBL] [Abstract][Full Text] [Related]
80. Purification of an outer capsid glycoprotein of neonatal calf diarrhea virus and preparation of its antisera. Matsuno S; Inouye S Infect Immun; 1983 Jan; 39(1):155-8. PubMed ID: 6295955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]